Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Italian Journal of Pediatrics
Published in: Italian Journal of Pediatrics 1/2019

Open Access 01-12-2019 | Insulins | Case report

Ventricular bigeminy and trigeminy caused by hypophosphataemia during diabetic ketoacidosis treatment: a case report

Authors: Konrad Miszczuk, Joanna Mroczek-Wacinska, Robert Piekarski, Beata Wysocka- Lukasik, Renata Jawniak, Iwona Ben-Skowronek

Published in: Italian Journal of Pediatrics | Issue 1/2019

Login to get access

Abstract

Background

Hypophosphatemia has many causes, and is often encountered during DKA (Diabetic Ketoacidosis) treatment. However, it rarely requires clinical intervention.

Case presentation

Ventricular arrhythmia was observed in a 10-year-old girl with newly diagnosed type 1 diabetes mellitus and hypophosphatemia while undergoing treatment for ketoacidosis. Oral phosphate supplementation ceased ventricular arrhythmia almost completely.

Conclusions

The clinical signs of hypophosphatemia are potentially life-threatening. Therefore, physicians should be vigilant when treating patients who are at risk of hypophosphatemia. Severe hypophosphatemia accompanied by clinical symptoms requires oral or intravenous supplementation of phosphate.
Literature
1.
ISPAD. Clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(Suppl 27):155–77.
2.
Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Sprank P. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care. 2010;14:R147.CrossRef
3.
Allgrove J, Shaw NJ, editors. Calcium and bone disorders in children and adolescents. 2nd End ed. Basel: Karger; 2015. p. 134–61. Endocr Dev
4.
Kliegman RM, Stanton BMD, St GJ, Schor NF, Behrman RE. Nelson textbook of pediatrics. 20th ed. Philadelphia: Elsevier; 2015.
5.
Assadi F. Hypophosphatemia: an evidence-based problem-solving approach to clinical cases. Iran J Kidney Dis. 2010;4(3):195–201.PubMed
6.
Bugg NC, Jones JA. Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia. 1998;53(9):895–902.CrossRef
7.
Guest G. Organic phosphates of the blood and mineral metabolism in diabetic acidosis. Am J Dis Child. 1942;64:401–12.CrossRef
8.
Guest G, Rapoport S. Electrolytes of blood plasma and cells in diabetic acidosis and during recovery. Proc Amer Diab Assoc. 1947;7:95–115.
9.
Shen T, Braude S. Changes in serum phosphate during treatment of diabetic ketoacidosis: predictive significance of severity of acidosis on presentation. Intern Med J. 2012;42(12):1347–50.CrossRef
10.
Jacob R, Patel RS, Fuentes F. Less phosphorus, more problems: hypophosphatemia induced polymorphic ventricular tachycardia in a young male. Int J Clin Cardiol. 2018;5:112.
11.
de Oliveira Iglesias SB, Pons Leite H, de Carvalho WB. Hypophosphatemia-induced seizure in a child with diabetic ketoacidosis. Pediatr Emer Care. 2009;25:859–61.CrossRef
12.
Ariyoshi N, Nogi M, Ando A, Watanabe H, Umekawa S. Cardiovascular consequences of hypophosphatemia. Panminerva Med. 2017;59:230–40.PubMed
13.
Choi HS, Kwon A, Chae HW, Suh J, Kim DH, Kim H-S. Respiratory failure in a diabetic ketoacidosis patient with severe hypophosphatemia. Ann Pediatr Endocrinol Metab. 2018;23:103–6.CrossRef
14.
Konstantinov NK, Rohrscheib M, Agaba EI, Dorin RI, Murata GH, Tzamaloukas AH. Respiratory failure in diabetic ketoacidosis. World J Diabetes. 2015;6(8):1009–23.CrossRef
15.
Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet. 2018;7:1–94.CrossRef
16.
Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol. 2000;36(6):1749–66.CrossRef
17.
Postema PG, Wilde AAM. The measurement of the QT interval. Curr Cardiol Rev. 2014;10(3):287–94.CrossRef
18.
Zieg J, Gonsorcikova L, Landau D. Current views on the diagnosis and management of hypokalaemia in children. Acta Paediatr. 2016;105(7):762–72.CrossRef
19.
Surawicz B. Electrolytes and the electrocardiogram. Am J Cardiol. 1963;12(5):656–62.CrossRef
20.
Saikawa T, Tsumabuki S, Nakagawa M, Takakura T, Tamura M, Maeda T, Ito S, Ito M. QT intervals as an index of high serum calcium in hypercalcemia. Clin Cardiol. 1988;11(2):75–8.CrossRef
21.
Riley MS, Schade DS, Eaton PR. Effect of insulin infusion on plasma phosphate in diabetic patients. Metabolism. 1979;28(3):191–4.CrossRef
22.
Mostellar ME, Tuttle EP. Effects of alkalosis on plasma concentration and urinary excretion of inorganic phosphate in man. J Clin Invest. 1964;43:138–49.CrossRef
23.
Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab. 2018;72(2):87–95.CrossRef
24.
Faruqi T, Hanhan U, Orlowski J, et al. Supraventricular tachycardia with underlying atrial flutter in a diabetic ketoacidosis patient. Clin Diabetes. 2015;33:146–9.CrossRef
25.
Thomas N, Scanlon J, Ahmed M. Supraventricular tachycardia in association with diabetic ketoacidosis. Br J Diabetes Vasc Dis. 2007;7:244–5.CrossRef
26.
McGreevy M, Beerman L, Arora G. Ventricular tachycardia in a child with diabetic ketoacidosis without heart disease. Cardiol Young. 2016;26:206–8.CrossRef
27.
Payne J, Noble C, Kaye R, et al. Atrial fibrillation and hyperamylasaemia in diabetic ketoacidosis. Br J Diabetes Vasc Dis. 2007;7:241–2.CrossRef
28.
Finn BP, Fraser B, O'Connell SM. Supraventricular tachycardia as a complication of severe diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes. BMJ Case Rep. 2018;15:2018.
29.
Ayón-Aguilar J, Valladares-Villalobos J, Santos-López G, Méndez -Martínez S. Diabetic ketoacidosis complicated by supraventricular tachycardia in a young adult: a case report. Investig Clin. 2018;59(2):155–60.
30.
Schwartz A, Brotfain E, Koyfman L, Kutz R, Gruenbaum SE, Klein M, Zlotnik A. Association between hypophosphatemia and cardiac arrhythmias in the early stage of sepsis: could phosphorus replacement treatment reduce the incidence of arrhythmias? Electrolyte Blood Press. 2014;12(1):19–25.CrossRef
31.
Stanga Z, Brunner A, Leuenberger M, Grimble RF, Shenkin A, Allison SP, Lobo DN. Nutrition in clinical practice-the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr. 2008;62(6):687–94.CrossRef
32.
Shiber JR, Mattu A. Serum phosphate abnormalities in the emergency department. J Emerg Med. 2002;23(4):395–400.CrossRef
33.
Miller DW, Slovis CM. Hypophosphatemia in the emergency department therapeutics. Am J Emerg Med. 2000;18(4):457–61.CrossRef
Metadata
Title
Ventricular bigeminy and trigeminy caused by hypophosphataemia during diabetic ketoacidosis treatment: a case report
Authors
Konrad Miszczuk
Joanna Mroczek-Wacinska
Robert Piekarski
Beata Wysocka- Lukasik
Renata Jawniak
Iwona Ben-Skowronek
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2019
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-019-0633-y

Other articles of this Issue 1/2019

Italian Journal of Pediatrics 1/2019 Go to the issue

Research

Hemostatic profile of infants with spontaneous prematurity: can we predict intraventricular hemorrhage development?

Research

The role of miR-29c/B7-H3/Th17 axis in children with Mycoplasma pneumoniae pneumonia

Research

The relationship between air quality and respiratory pathogens among children in Suzhou City

Letter to the Editor

Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice

Case report

Hepatomegaly and type 1 diabetes: a clinical case of Mauriac’s syndrome

Review

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?